title: Role of diradylglycerol formation in H2O2 and lactoferrin release in adherent human polymorphonuclear leukocytes.
abstract: Polymorphonuclear leukocytes (PMNs) adherent to fibrinogen exhibit a delay in the release of H2O2 in response to fMLP. Previously, we demonstrated that H2O2 release in adherent PMNs coincides with the exocytosis of lactoferrin-containing specific granules and activation of phospholipase D (PLD). We also found that chelation of intracellular calcium blocked both lactoferrin and H2O2 release in stimulated PMNs in spite of the fact that adhesion and spreading remained normal. Since diradylglycerol (DRG) formation has been implicated in PMN secretion and oxidant release, we determined the effect of intracellular calcium chelation on PLD activation and DRG formation to ascertain whether DRG formation was coupled to lactoferrin and H2O2 release. We observed that chelation of intracellular calcium with bis-(O-aminophenoxy)-ethanol-N,N;N'-tetraacetic acid (BAPTA) prevented PLD activation as monitored by inhibition of phosphatidylethanol formation. Formation of DRG derived from phosphatidic acid (PA) was also inhibited in the presence of BAPTA. Following the addition of the calcium ionophore ionomycin to the BAPTA-treated PMNs, lactoferrin and H2O2 release was coincident with the onset of DRG formation. Also the addition of sn-1,2-didecanoylglycerol to the BAPTA-treated PMNs stimulated them to release H2O2. Our studies support the hypothesis that DRG derived from PLD activation is required for degranulation of specific granules and associated H2O2 release from adherent PMNs.
authors.affiliation: Department of Pediatrics, University of Michigan, Ann Arbor.
authors.forename: T
authors.initials: T
authors.lastname: Nakamura
authors.forename: S J
authors.initials: SJ
authors.lastname: Suchard
authors.forename: A
authors.initials: A
authors.lastname: Abe
authors.forename: J A
authors.initials: JA
authors.lastname: Shayman
authors.forename: L A
authors.initials: LA
authors.lastname: Boxer
mesh_terms: D000595:Amino Acid Sequence; D002118:Calcium / Q000378:metabolism; D002448:Cell Adhesion / Q000502:physiology; D002478:Cells, Cultured; D002614:Chelating Agents / Q000494:pharmacology; D004075:Diglycerides / Q000096:biosynthesis*; D004533:Egtazic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D004789:Enzyme Activation; D005089:Exocytosis / Q000502:physiology; D005340:Fibrinogen; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism*; D007202:Indicators and Reagents / Q000494:pharmacology; D007424:Intracellular Fluid / Q000378:metabolism; D007781:Lactoferrin / Q000378:metabolism* / Q000502:physiology; D008969:Molecular Sequence Data; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D010739:Phospholipase D / Q000097:blood / Q000378:metabolism
chemical_list: D002614:Chelating Agents; D004075:Diglycerides; D007202:Indicators and Reagents; C070379:1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester; D004533:Egtazic Acid; D009240:N-Formylmethionine Leucyl-Phenylalanine; C035561:diarachidonyl diglyceride; D005340:Fibrinogen; D006861:Hydrogen Peroxide; D010739:Phospholipase D; D007781:Lactoferrin; C025603:1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; D002118:Calcium